Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mataix

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revista Clinica Espanola|July 1, 1994
[Bone marrow aplasia and gold salts. Review of the literature apropos of 2 cases]M C Pérez, M T Gómez Casares, R Mataix, et al.
Sangre|December 1, 1995
[Splenic lymphoma with circulating hairy lymphocytes lymphoma. Clinical cytological study of 4 patients]S Jiménez, T Molero, C Santana, et al.
Haematologica|April 11, 2000
Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantationM f Del Cañizo, M f Amigo, J M Hernández, et al.
British Journal of Haematology|September 21, 2001
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantationD Gallardo, J I Aróstegui, A Balas, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative GroupA Sureda, R Arranz, A Iriondo, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?J F San Miguel, J J Lahuerta, R García-Sanz, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revista Clinica Espanola|July 1, 1994
[Bone marrow aplasia and gold salts. Review of the literature apropos of 2 cases]M C Pérez, M T Gómez Casares, R Mataix, et al.
Sangre|December 1, 1995
[Splenic lymphoma with circulating hairy lymphocytes lymphoma. Clinical cytological study of 4 patients]S Jiménez, T Molero, C Santana, et al.
Haematologica|April 11, 2000
Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantationM f Del Cañizo, M f Amigo, J M Hernández, et al.
British Journal of Haematology|September 21, 2001
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantationD Gallardo, J I Aróstegui, A Balas, et al.
Bone Marrow Transplantation|August 1, 1997
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative groupA Sureda, R Mataix, F Hernández-Navarro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcomeM Constans, A Sureda, M J Terol, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative GroupA Sureda, R Arranz, A Iriondo, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?J F San Miguel, J J Lahuerta, R García-Sanz, et al.
Pageof 1